Discounted Cash Flow Rating

Strong Sell

Return on Equity Rating

Sell

Debt to Equity Rating

Buy

Price to Earnings Rating

Buy

Analyst Rating

Neutral

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Standard Deviation

Sell

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Strong Buy

Wall Street Data Solutions Rating

Neutral

B

Bolt Biotherapeutics, Inc. Common Stock (BOLT)

Pharmaceutical Preparations

https://www.boltbio.com

Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems.

900 CHESAPEAKE DRIVE
REDWOOD CITY, CA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

02/05/2021

Market Cap

26,536,639

Shares Outstanding

37,970,000

Weighted SO

37,965,870

Total Employees

N/A

Upcoming Earnings

08/05/2024

Similar Tickers

ASMB --.--%

NLTX --.--%

TIL --.--%

CTMX --.--%

ACHL --.--%

SPRO --.--%

NUVB --.--%

NXTC --.--%

Beta

0.9340

Last Div

0.0000

Range

0.65-1.56

Chg

0.0025

Avg Vol

206017

Mkt Cap

26536639

Exch

NASDAQ

Country

US

Phone

650 665 9295

DCF Diff

1.2459

DCF

-0.0459

Div Yield

0.0000

P/S

2.3766

EV Multiple

-0.5398

P/FV

0.3080

Div Yield %

0.0000

P/E

-0.3996

PEG

-0.0196

Payout

0.0000

Current Ratio

4.2811

Quick Ratio

4.2811

Cash Ratio

0.3465

DSO

22.8820

DIO

0.0000

Op Cycle

22.8820

DPO

511.6622

CCC

-488.7803

Gross Margin

0.8322

Op Margin

-6.6338

Pretax Margin

-5.9257

Net Margin

-5.9257

Eff Tax Rate

-0.0280

ROA

-0.5328

ROE

-0.6140

ROCE

-0.6970

NI/EBT

1.0000

EBT/EBIT

0.8933

EBIT/Rev

-6.6338

Debt Ratio

0.1521

D/E

0.2200

LT Debt/Cap

0.1562

Total Debt/Cap

0.1803

Int Coverage

-51.6188

CF/Debt

-3.3829

Equity Multi

1.4463

Rec Turnover

15.9514

Pay Turnover

0.7134

Inv Turnover

0.0000

FA Turnover

0.5160

Asset Turnover

0.0899

OCF/Share

-1.6761

FCF/Share

-1.6806

Cash/Share

1.9329

OCF/Sales

-5.7234

FCF/OCF

1.0027

CF Coverage

-3.3829

ST Coverage

-21.3379

CapEx Coverage

-373.7251

Div&CapEx Cov

-373.7251

P/BV

0.3080

P/B

0.3080

P/S

2.3766

P/E

-0.3996

P/FCF

-0.4141

P/OCF

-0.4138

P/CF

-0.4138

PEG

-0.0196

P/S

2.3766

EV Multiple

-0.5398

P/FV

0.3080

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. Aug 30, 00:49 DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Bolt GlobeNewswire Inc. Aug 27, 01:00 Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against CVS, Walgreens, SeaStar, and Bolt and Encourages Investors to Contact the Firm GlobeNewswire Inc. Aug 07, 01:00 Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against CVS, Walgreens, SeaStar, and Bolt and Encourages Investors to Contact the Firm GlobeNewswire Inc. Jul 25, 22:43 ROSEN, LEADING TRIAL ATTORNEYS, Encourages Bolt Biotherapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – BOLT GlobeNewswire Inc. Oct 23, 10:30 Bolt Biotherapeutics Presents Updated Clinical Data from Phase 1 Dose-Escalation Trial of BDC-1001 as Monotherapy and in Combination with Nivolumab in HER2-Expressing Tumors at ESMO 2023 Congress GlobeNewswire Inc. Oct 23, 10:30 Bolt Biotherapeutics Presents Updated Clinical Data from Phase 1 Dose-Escalation Trial of BDC-1001 as Monotherapy and in Combination with Nivolumab in HER2-Expressing Tumors at ESMO 2023 Congress

Revenue Product Segmentation

Dividend History

Cash Value Ex-Dividend Date Declaration Date Record Date Pay Date
0.09 08/29/2014 08/13/2014 11/30/-0001 10/02/2014
0.09 06/10/2014 04/24/2014 11/30/-0001 07/09/2014
0.09 03/03/2014 01/22/2014 11/30/-0001 04/02/2014
0.09 12/30/2013 11/27/2013 11/30/-0001 01/15/2014
0.09 09/03/2013 08/14/2013 11/30/-0001 10/03/2013
0.07 06/03/2013 04/24/2013 11/30/-0001 07/05/2013
0.07 03/05/2013 01/25/2013 11/30/-0001 04/04/2013
0.07 11/30/2012 11/21/2012 11/30/-0001 12/18/2012
0.07 09/04/2012 08/22/2012 11/30/-0001 10/04/2012
0.05 06/04/2012 04/26/2012 11/30/-0001 07/06/2012
0.05 03/06/2012 01/25/2012 11/30/-0001 04/05/2012